  World News (12)
  World Business (847)
 USA (336)
 California (187)
 Bay Area (12)
Bay Area Business (1699)
 North East Bay (1964)
Alameda County (451)
Emeryville (91)
  Chiron (30)
 2006 (2)
2005 (12)
2004 (8)
2003 (5)
2002 (2)
2001 (1)
 Emeryville Chiron on Wikipedia
 Emeryville Chiron on Web
|
|
|
| Apr.20 |
 |
Chiron shareholders OK sale to Novartis Shareholders approved a $5.4 billion acquisition by Swiss drug giant Novartis, ending the independent existence
|
| Feb.7 |
 |
Chiron Cleared in SEC Investigation Regulators have decided not to sanction the company following a probe into the suspension of its flu vaccine license
|
|
| Nov.4 |
|
Novartis picks chief to head Chiron uni Swiss pharmaceutical giant named Dr. Joerg Reinhardt, 49, as the leader of the new division if its $5.1 billion acquisition
|
| Nov.1 |
|
Novartis to buy Chiron| Chiron's board accepted a $5.1 billion purchase offer from Swiss pharmaceutical giant Novartis AG | |
|
| Oct.18 |
|
Problems Cause Chiron To Miss Earnings Chiron Corp. won't ship as many flu shots as it initially had hoped
|
| Oct.13 |
 |
Chiron gets OK on flu shots FDA had released three lots of Chiron's product Fluvirin
|
| Sep.7 |
|
Chiron shares head upward Investors hope that Novartis will boost a $4.5 billion purchase offer that the biotechnology firm turned down
|
| Sep.1 |
|
$4.5B Offered to Finish Chiron Takeover Novartis is offering $4.5 billion in cash for the remaining stake in Chiron to complete its takeover
|
| Jul.28 |
|
Chiron's earnings hit hard The losses from the back-to-back failures of 2 flu vaccine manufacturing plants eroded profits
|
| Jun.15 |
|
Chiron Warns on Fewer Flu Vaccines| Chiron will not produce as many flu vaccines as previously announced because of production delays | |
|
| Jun.7 |
|
Drug panel divided on Chiron medicine Chiron is holding out hope that regulators will approve its inhaled medicine to prevent lung transplant rejection
|
| Apr.28 |
|
Flu shot problem hurts Chiron's profit 1st-quarter results fell well short of analysts' expectations
|
| Mar.2 |
|
Regulators Lift Suspension on Chiron| British regulators are enabling the company to begin reproducing flu drugs | |
|
| Jan.26 |
|
Chiron's 2004 income falls dramatically Chiron hobbled by its failure to deliver half the nation's flu vaccine last year. It missed analysts' expectations
|
|
| Oct.20 |
|
Flu Vaccine Fiasco Costs Chiron Millions Vaccine fiasco will cost the company $91 million
|
| Oct.15 |
|
Board member quits embattled Chiron The company announced the resignation of Richard Wills, chief executive of Tektronix, in a one-sentence press release
|
| Oct.13 |
|
SEC probes Chiron over flu shot shortage The commission has launched an inquiry into how Chiron handled the disclosure of vaccine-manufacturing problems
|
| Oct.5 |
 |
Health Dept. Cancels Flu Shot Clinics SF City Hall: The department cancelled its clinics for November, after problems with a Chiron sparked warnings of a vaccine shortage
|
| |
|
Flu maker Chiron slashes profit outlook| Chiron cut its profit forecast by more than half after British officials pulled the company's license | |
|
| Aug.20 |
|
Chiron gets temporary restraining order
|
| Jul.8 |
|
Chiron fined for trading with Cuba
|
| Feb.27 |
|
Chiron sues animal activists| Chiron is accusing the activists of waging a violent harassment campaign and supporting the man charged with bombing | |
|
|
| Dec.16 |
|
Chiron sells 375,000 additional flu vaccine U.S. Health Secretary Thompson has announced the purchase from pharmaceutical company
|
| Aug.29 |
|
FBI opens domestic terrorism probe
|
| Aug.28 |
|
2 small blasts near Chiron offices| No injuries were reported in the blasts, which hit around 3 a.m. and 4 a.m. Chiron makes vaccines and drugs | |
|
| May.19 |
|
Chiron to buy vaccine maker PowderJect| Chiron will buy British rival for about $878 million | |
|
| Mar.20 |
|
Chiron names new chief executive Biotechnology company appointed former GlaxoSmithKline Plc executive Howard Pien its new CEO and president
|
|
| Sep.7 |
|
Big patent win vs. Chiron Genentech: Chiron of Emeryville has no claim to any profits from Genentech's blockbuster breast cancer drug, Herceptin
|
| Jan.8 |
|
Chiron to buy Matrix| Fremont: Emeryville's Chiron would buy biotech firm Matrix Pharmaceuticals for $61 million in cash | |
|
|
| Mar.12 |
|
Chiron has good year| Since the beginning of 2001, biotech stock down 16 percent, but Chiron is ahead 1 percent | |
|
|
Add a favorite (file a bookmark) to Emeryville, Chiron Timeline
Please send feedback to: support@mapreport.com
Advertise on Emeryville, Chiron Page
Neighbor  Real Estate:
XML
|
Chiron (30)
Main Event: Big patent win vs. Chiron